How India is deploying AI across its healthcare system — from 797 million digital health IDs and 430 million teleconsultations to AI-powered TB screening that cut adverse outcomes by 27% and cardiac AI that reduced ICU mortality by 40%.
The Ayushman Bharat Digital Mission (ABDM), launched September 2021 with ₹1,600 crore over five years, has created 797 million ABHA IDs — unique digital health identifiers — covering all 36 states and UTs across 786 districts. The system has linked 651 million health records, with 417,000 health facilities and 676,000 healthcare professionals registered.
Federated architecture for privacy: Patient data always resides at the source facility, exchanged only through a consent manager using FHIR, SNOMED-CT, ICD-10, and LOINC standards. The Unified Health Interface (UHI) — analogous to UPI for health — and National Health Claims Exchange (NHCX) are under active rollout.
eSanjeevani, India's telemedicine platform by C-DAC Mohali, has completed 430 million teleconsultations across 155,000 public health facilities with 224,000 doctors onboarded. Peak capacity exceeds 1 million consultations per day, with 93% using the hub-and-spoke model connecting rural Health and Wellness Centres to specialist hubs. The platform has begun integrating AI for automated query sorting and delivered 12 million AI-assisted diagnoses by late 2025.
The CoWIN vaccination platform administered 2.2 billion vaccine doses across 470,000+ centres (73% rural), trained 1.2 million frontline workers, and set India's single-day record of 25 million doses. The platform was offered as a global digital public good and adopted by Bangladesh, Indonesia, Vietnam, and Bhutan.
Aarogya Setu became the world's fastest-growing app with 50 million downloads in 13 days, peaking at 200 million+ downloads. Its integration with IIT Madras's ITIHAS system enabled district-level hotspot detection — in Gujarat's Anand district, it found two hidden COVID hotspots 17 days before manual investigation could.
Ayushman Bharat PM-JAY, covering 550 million individuals, has authorized 10.98 crore hospital admissions worth ₹1.60 lakh crore. The National Health Authority's AI/ML anti-fraud framework — combining rule-based triggers, machine learning, image classification, and de-duplication — analyzes 11 crore+ treatment records.
Results: 5.3 lakh cards disabled, 1,114 hospitals de-empanelled, ₹122 crore in penalties, and approximately ₹630 crore in fraud prevented over two years. Aadhaar-based face authentication now verifies every hospital admission and discharge.
India carries 27–28% of the global TB burden with 2.78 million new cases annually. AI integration has delivered a 27% decline in adverse TB outcomes and a 12–16% increase in case detection.
In Mumbai's MCGM hospitals, screened 100,000+ individuals — 35% of TB detections were incidental (from non-TB pathways) and 26% of AI-flagged cases were confirmed TB. In Chhattisgarh, positive TB notifications increased over 100%. In Nagpur, produced a 20% increase in notifications and 50% increase in bacteriological confirmations.
At the 2025 Maha Kumbh Mela (~50 crore attendees), qXR flagged 36% of X-rays as abnormal and 12% as presumptive TB — the first time AI was used for TB surveillance at a mass gathering of this scale. WHO has endorsed AI chest X-ray screening with 6 products now meeting performance standards.
Deployed at Aravind Eye Hospital across 45 sites in Southern India, achieving 94.7% accuracy, 91.4% sensitivity, and 95.4% specificity (Lancet-published). Google licensed the tech to Indian manufacturers with a target of 6 million free screenings over 10 years. With Apollo Radiology: 3 million free AI cancer screenings planned over the next decade.
Microsoft's MINE (Intelligent Network for Eyecare) with L.V. Prasad Eye Institute operates across 174 centres. The AICVD cardiovascular risk API co-developed with Apollo Hospitals was validated by Maastricht University and deployed across Apollo Health Check centres nationwide.
Andhra Pradesh deployed ~40 AI-enabled devices from 18 startups across 18 government hospitals, screening for 15 disease types. CM Naidu proposed an "One AI Doctor Per Person" model. Telangana established T-AIM with NASSCOM (₹400+ crore, 900+ AI startups) and launched AI cancer screening plus India's first drone medical delivery. Karnataka deployed AI dialysis monitoring achieving 85–95% accuracy. Tamil Nadu piloted AI diagnosis at Royapettah Hospital for TB, eye disorders, and cancers. UP opened India's first government hospital-based AI clinic at GIMS Greater Noida.
The IIT Delhi–AIIMS AI Centre of Excellence launched with ₹330 crore funding, focusing on early cancer detection and vector-borne diseases. MadhuNetrAI screened 7,100 patients across 38 facilities, achieving 98% sensitivity for diabetic retinopathy. The oncology AI program trained on 500,000 images from 1,500 cancer cases and deployed to 5 district hospitals.
AI-powered imaging with Medtronic reduced stroke diagnosis from 60 min → 2 min. Dozee remote monitoring achieved 80% reduction in Code Blue events, zero CCU deaths post-deployment, 70% reduction in nurse workload, and 26% cut in ward costs. Voice AI (Augnito) saves doctors 44 hours/month, enabling 23,800 additional consultations monthly with ₹21 return for every ₹1 invested.
India's DPDP Act (2023) notably does not classify health data as "sensitive personal data" — a regression from earlier drafts. Full provisions take effect May 2027. CDSCO released a 76-page draft guidance on Medical Device Software with risk-based classification (Class A–D), but awaits finalization. ICMR's ethical guidelines for AI in healthcare remain advisory and non-binding.
Rural infrastructure remains the critical barrier: doctor-population ratio of 1:10,000 (vs WHO's 1:1,000), 80% of doctors in urban areas, 57% specialist shortfall at Community Health Centres, rural internet at ~37–40%, and government health spending at just 1.28% of GDP.
Approximately 50% of Indian pharma companies are exploring generative AI, with 25% in live production. Sun Pharma uses AI for molecule screening targeting TB and diabetes. Cipla integrated AI into smart inhalers. Biocon invests in protein modelling for cancer. Indegene achieved a 90% reduction in time-to-market for a global pharma client using GenAI. India's biotech ecosystem now exceeds 10,000 firms, and WHO recognized India's AI-Ayurgenomics integration as a "global model."
India's AI healthcare transformation is defined by three distinctive characteristics. First, digital public infrastructure at unprecedented scale — nearly 800 million health IDs, 430 million teleconsultations, 2.2 billion vaccinations digitally tracked. Second, measurable clinical outcomes: 27% decline in adverse TB outcomes, 40% reduction in Tele-ICU mortality, 80% reduction in Code Blue events, and stroke diagnosis compressed from an hour to two minutes. Third, an ecosystem spanning government missions (₹10,372 crore IndiaAI commitment) to globally competitive startups (Qure.ai in 90+ countries, Tricog screening 31 million patients).
The critical bottleneck is execution in the hardest-to-reach settings. With 80% of doctors in urban areas and rural internet below 40%, the gap between India's AI healthcare potential and equitable access remains substantial.
AiBOUT builds custom AI solutions for healthcare providers — from diagnostic imaging analytics and patient monitoring systems to hospital automation and predictive health tools. Tell us what you need and we'll build it.
Contact Us